TVTX
Travere Therapeutics, Inc. · Healthcare · Biotechnology
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 113 | +16 | 68.16M | $3.63B | +20 | −4 |
| Q1 2026 | 100 | -5 | 69.82M | $2.07B | +9 | −14 |
| Q4 2025 | 104 | +1 | 74.66M | $2.85B | +1 | — |
| Q3 2025 | 21 | +1 | 36.01M | $860.71M | +2 | −2 |
| Q2 2025 | 18 | +1 | 30.33M | $448.83M | +2 | −1 |
| Q1 2025 | 14 | 0 | 16.78M | $300.70M | — | — |
| Q4 2024 | 14 | +1 | 16.09M | $280.22M | +2 | −1 |
| Q3 2024 | 12 | -1 | 7.80M | $109.09M | +1 | −2 |
| Q2 2024 | 13 | — | 10.32M | $84.85M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Millennium Management ✦ | 2.95M | — | $24.24M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Renaissance Technologies ✦ | 2.20M | — | $18.12M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasivo) | 1.67M | — | $13.70M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasivo) | 1.67M | — | $13.70M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | D. E. Shaw & Co. ✦ | 1.53M | — | $12.60M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 1.53M | — | $12.60M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 640.31K | — | $5.26M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 640.31K | — | $5.26M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Adage Capital Partners ✦ | 400.00K | — | $3.29M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Point72 Asset Management ✦ | 320.58K | — | $2.64M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 314.18K | — | $2.58M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 74.07K | — | $608,848 | 0.0% | n/c | 1 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 74.07K | — | $608,848 | 0.0% | n/c | 1 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 74.07K | — | $608,848 | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Wellington Management ✦ | 72.66K | — | $597,249 | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Wellington Management ✦ | 72.66K | — | $597,249 | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Wellington Management ✦ | 72.66K | — | $597,249 | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Wellington Management ✦ | 72.66K | — | $597,249 | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Norges Bank ✦ (pasivo) | 71.00K | — | $583,620 | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Fisher Asset Management ✦ | 43.18K | — | $354,956 | 0.0% | n/c | 1 | SEC ↗ |
| 21 | T. Rowe Price ✦ | 33.44K | — | $275,000 | 0.0% | n/c | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1 tenedores, 121.20K acciones, $3,600 declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Director · 4.10K acc. · $259,390
Director · 900 acc. · $57,470
Director · 500 acc. · $32,081
Director · 1.90K acc. · $118,805
Director · 2.60K acc. · $165,100
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología